Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001797503 | SCV002039075 | uncertain significance | not provided | 2021-06-18 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; Not observed at significant frequency in large population cohorts (Lek et al., 2016); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 27535533) |
Labcorp Genetics |
RCV001797503 | SCV002203050 | likely benign | not provided | 2024-08-11 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003346696 | SCV004060164 | uncertain significance | Inborn genetic diseases | 2023-08-14 | criteria provided, single submitter | clinical testing | The c.3401C>T (p.P1134L) alteration is located in exon 44 (coding exon 44) of the COL11A1 gene. This alteration results from a C to T substitution at nucleotide position 3401, causing the proline (P) at amino acid position 1134 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |